A carregar...
Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy
BACKGROUND: Azilsartan (AZI) is a relatively new angiotensin receptor blocker available for the treatment of any stage of hypertension, which was eventually given in combination with chlorthalidone (CLT). OBJECTIVE: To review pharmacology and clinical role of AZI monotherapy and AZI/CLT or AZI/amlod...
Na minha lista:
| Publicado no: | Core Evid |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4829189/ https://ncbi.nlm.nih.gov/pubmed/27103882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S81776 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...